NFL Biosciences

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock

NFL Biosciences secures €1.2m non-dilutive funding to accelerate Phase 3 development of NFL-101

Find out how NFL Biosciences secured €1.2 million non-dilutive funding to accelerate Phase 3 of NFL-101, a first-in-class botanical smoking cessation drug.

byPallavi Madhiraju

July 22, 2025

Themis Medicare, NFL Biosciences partner on smoking cessation candidate NFL-101

Indian pharmaceutical company Themis Medicare has joined hands with French biotech company NFL Biosciences to develop NFL-101, a…

byPallavi Madhiraju

October 10, 2022

The Latest

Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock

NFL Biosciences secures €1.2m non-dilutive funding to accelerate Phase 3 development of NFL-101

Themis Medicare, NFL Biosciences partner on smoking cessation candidate NFL-101

Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock

Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)